Search bioRxiv⌕ Search

Biology subjects

Oelze, M.

Publications and source records attributed to Oelze, M..

2 recordsLinked to original sources

Null Subtraction Imaging for Functional Ultrasound Brain Activation Mapping

Null Subtraction Imaging (NSI) is a nonlinear beamforming approach that combines multiple receive apodizations and subtraction to improve spatial resolution in ultrasound imaging. In NSI, a DC offset parameter is introduced in the apodization design to control the sharpening of the effective beam pattern and, therefore, the degree of spatial-resolution enhancement. Here, we investigate the use of NSI in functional ultrasound (fUS) imaging of the mouse brain and compare its performance with conventional delay-and-sum (DAS) beamforming across a range of DC offset values. fUS acquisitions were performed in three anesthetized wild-type mice during periodic vibrissae stimulation. Activation maps were computed by correlating cerebral blood volume (CBV) signals with the stimulation pattern. Activation area, edge gradient, Dice similarity coefficient, and signal-to-noise ratio (SNR) were used to evaluate spatial localization, boundary sharpness, vascular alignment and signal stability, respectively. NSI yielded more spatially confined activation maps than DAS and produced sharper activation boundaries. However, for low DC offsets (DC < 0.5), the CBV signal exhibited increased fluctuations, which reduced temporal stability and limited the reliability of the functional maps. As the DC offset increased, temporal SNR improved, while the spatial-resolution gain progressively decreased. In our imaging configuration, intermediate DC values around DC {approx} 0.5 provided the most favorable compromise between improved spatial localization and sufficient temporal stability for reliable functional activation detection. These results demonstrate the feasibility of applying NSI to functional ultrasound imaging and provide a quantitative framework for selecting the DC parameter in fUS studies.

bioengineering↗

In vivo validation of an in situ calibration bead as a reference for backscatter coefficient calculation

ObjectivesThe study aims to assess the capability of Quantitative Ul-trasound (QUS) based on the backscatter coefficient (BSC) for classifying disease states, such as breast cancer response to neoadjuvant chemotherapy and quantifying fatty liver disease. We evaluate the effectiveness of an in situ titanium (Ti) bead as a reference target in calibrating the system and mitigating attenuation and transmission loss effects on BSC estimation. MethodsTraditional BSC estimation methods require external references for calibration, which do not account for ultrasound attenuation or transmis-sion losses through tissues. To address this issue, we use an in situ titanium (Ti) bead as a reference target, because it can be used to calibrate the system and mitigate the attenuation and transmission loss effects on estimation of the BSC. The capabilities of the in situ calibration approach were assessed by quantifying consistency of BSC estimates from rabbit mammary tumors (N = 21). Specifically, mammary tumors were grown in rabbits and when a tumor reached 1 cm or greater in size, a 2-mm Ti bead was implanted into the tumor as a radiological marker and a calibration source for ultrasound. Three days later, the tumors were scanned with a L-14/5 38 array transducer connected to a SonixOne scanner with and without a slab of pork belly placed on top of the tumors. The pork belly acted as an additional source of attenu-ation and transmission loss. QUS parameters, specifically effective scatterer diameter (ESD) and effective acoustic concentration (EAC), were calculated using calibration spectra from both an external reference phantom and the Ti bead. ResultsFor ESD estimation, the 95% confidence interval between measure-ments with and without the pork belly layer was (6.0,27.4) using the in situ bead and (114, 135.1) with the external reference phantom. For EAC esti-mation, the 95% confidence interval were (-8.1, 0.5) for the bead and (-41.5, -32.2) for the phantom. These results indicate that the in situ bead method shows reduced bias in QUS estimates due to intervening tissue losses. ConclusionsThe use of an in situ Ti bead as a radiological marker not only serves its traditional role but also effectively acts as a calibration target for QUS methods. This approach accounts for attenuation and transmission losses in tissue, resulting in more accurate QUS estimates and offering a promising method for enhanced disease state classification in clinical settings.

bioengineering↗